The Auerbach trial in 2004 probably included patients with an absolute iron deficiency since one inclusion criterion was ferritin ≤200 μg/L or <300 μg/L with transferrin saturation ≤19% [26]. This evidence concerns the gene TF and Iron deficiency anemia.